Osteoarthritis is a degenerative condition that is highly prevalent and primarily affects the joints. The knee is the most commonly affected site, impacting the lives of over 300 million individuals worldwide. This study presents a potential solution to address the unmet need for a minimally invasive technique in the treatment of osteoarthritis: a biocompatible, injectable, and thermoresponsive hydrogel. In comparison to commercially available products such as lyophilized platelets, dextrose, and triamcinolone, the thermoresponsive hydrogel exhibits significantly superior performance in dynamic behaviors, including print area, stability, and step cycle, when tested on rats with knee osteoarthritis. However, it demonstrates similar treatment efficacy to these products in static behaviors, as observed through histopathological and immunohistochemical analysis. Therefore, the thermoresponsive hydrogel holds promise as an effective alternative therapy for osteoarthritis. Moreover, by blending the hydrogel with drugs, controlled and sustained release can be achieved, thereby facilitating the long-term management of osteoarthritis symptoms.
KloppenburgMBerenbaumF. Osteoarthritis year in review 2019: epidemiology and therapy. Osteoarthritis Cartilage2020; 28: 242–248. DOI: 10.1016/j.joca.2020.01.002
2.
DiseaseGBDInjuryIPrevalenceC. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet2016; 388: 1545–1602. DOI: 10.1016/S0140-6736(16)31678-6
3.
LiuQNiuJHuangJ, et al.Knee osteoarthritis and all-cause mortality: the Wuchuan Osteoarthritis study. Osteoarthritis Cartilage2015; 23: 1154–1157. DOI: 10.1016/j.joca.2015.03.021
4.
KimJRYooJJKimHA. Therapeutics in osteoarthritis based on an understanding of its molecular pathogenesis. Int J Mol Sci. 2018; 19: 674. doi:10.3390/ijms19030674
5.
DiekmanBOGuilakF. Stem cell-based therapies for osteoarthritis: challenges and opportunities. Curr Opin Rheumatol2013; 25: 119–126. DOI: 10.1097/BOR.0b013e32835aa28d
6.
HunterDJ. Osteoarthritis management: time to change the deck. J Orthop Sports Phys Ther2017; 47: 370–372. DOI: 10.2519/jospt.2017.0605
7.
HealthNif.ExcellenceC. Osteoarthritis in over 16s: diagnosis and management. London: National Institute for Health and Care Excellence (NICE), 2022.
8.
GregoriDGiacovelliGMintoC, et al.Association of pharmacological treatments with long-term pain control in patients with knee osteoarthritis: a systematic review and meta-analysis. JAMA2018; 320: 2564–2579. DOI: 10.1001/jama.2018.19319
9.
GrosserTRicciottiEFitzGeraldGA. The cardiovascular pharmacology of nonsteroidal anti-inflammatory drugs. Trends Pharmacol Sci2017; 38: 733–748. DOI: 10.1016/j.tips.2017.05.008
10.
FilardoGKonELongoUG, et al.Non-surgical treatments for the management of early osteoarthritis. Knee Surg Sports Traumatol Arthrosc2016; 24: 1775–1785. DOI: 10.1007/s00167-016-4089-y
11.
PengYNChenJLHsuCC, et al.Intra-articular leukocyte-rich platelet-rich plasma versus intra-articular hyaluronic acid in the treatment of knee osteoarthritis: a meta-analysis of 14 randomized controlled trials. Pharmaceuticals2022; 15. DOI: 10.3390/ph15080974
12.
da SilvaLQMontalvãoSAdLJusto-JuniorAdS, et al.Platelet-rich plasma lyophilization enables growth factor preservation and functionality when compared with fresh platelet-rich plasma. Regen Med2018; 13: 775–784. DOI: 10.2217/rme-2018-0035
13.
AndiaIPerez-ValleADel AmoC, et al.Freeze-drying of platelet-rich plasma: the quest for standardization. Int J Mol Sci2020; 21. DOI: 10.3390/ijms21186904
14.
WangLLChungJJLiEC, et al.Injectable and protease-degradable hydrogel for siRNA sequestration and triggered delivery to the heart. J Contr Release2018; 285: 152–161. DOI: 10.1016/j.jconrel.2018.07.004
15.
WuCHSunMKKungY, et al.One injection for one-week controlled release: in vitro and in vivo assessment of ultrasound-triggered drug release from injectable thermoresponsive biocompatible hydrogels. Ultrason Sonochem2020; 62: 104875. DOI: 10.1016/j.ultsonch.2019.104875
16.
KungYChienWCHuangHY, et al.Ultrasound-controlled release of growth factors from lyophilized platelet-loaded thermoresponsive hydrogel. International Journal of Polymeric Materials and Polymeric Biomaterials2023: 1–9. DOI: 10.1080/00914037.2023.2221007
17.
CifuentesDJRochaLGSilvaLA, et al.Decrease in oxidative stress and histological changes induced by physical exercise calibrated in rats with osteoarthritis induced by monosodium iodoacetate. Osteoarthritis Cartilage2010; 18: 1088–1095. DOI: 10.1016/j.joca.2010.04.004
18.
OtisCGervaisJGuillotM, et al.Concurrent validity of different functional and neuroproteomic pain assessment methods in the rat osteoarthritis monosodium iodoacetate (MIA) model. Arthritis Res Ther2016; 18: 150. DOI: 10.1186/s13075-016-1047-5
19.
RodriguesTAde Oliveira FreireACarvalhoHCO, et al.Prophylactic and therapeutic use of strontium ranelate reduces the progression of experimental osteoarthritis. Front Pharmacol2018; 9: 975. DOI: 10.3389/fphar.2018.00975
20.
XuYTianNXBaiQY, et al.Gait assessment of pain and analgesics: comparison of the digigait and catwalk gait imaging systems. Neurosci Bull2019; 35: 401–418. DOI: 10.1007/s12264-018-00331-y
21.
VieiraWFMalangeKFde MagalhãesSF, et al.Gait analysis correlates mechanical hyperalgesia in a model of streptozotocin-induced diabetic neuropathy: a CatWalk dynamic motor function study. Neurosci Lett2020; 736: 135253. DOI: 10.1016/j.neulet.2020.135253
22.
SchmitzNLavertySKrausVB, et al.Basic methods in histopathology of joint tissues. Osteoarthritis Cartilage2010; 18(Suppl 3): S113–S116. DOI: 10.1016/j.joca.2010.05.026
23.
BoveSECalcaterraSLBrookerRM, et al.Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. Osteoarthritis Cartilage2003; 11: 821–830. DOI: 10.1016/s1063-4584(03)00163-8
24.
van der KraanPMVittersELvan de PutteLB, et al.Development of osteoarthritic lesions in mice by “metabolic” and “mechanical” alterations in the knee joints. Am J Pathol1989; 135: 1001–1014.
25.
GuingampCGegout-PottiePPhilippeL, et al.Mono-iodoacetate-induced experimental osteoarthritis: a dose-response study of loss of mobility, morphology, and biochemistry. Arthritis Rheum1997; 40: 1670–1679. DOI: 10.1002/art.1780400917
26.
GuzmanREEvansMGBoveS, et al.Mono-iodoacetate-induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritis. Toxicol Pathol2003; 31: 619–624. DOI: 10.1080/01926230390241800
27.
de Sousa ValenteJ. The Pharmacology of pain associated with the monoiodoacetate model of osteoarthritis. Front Pharmacol2019; 10: 974. DOI: 10.3389/fphar.2019.00974
BinderH, et al.Clinical evaluation after matrix-associated autologous chondrocyte transplantation: a comparison of four different graft types. Bone Joint Res2021; 10: 370–379. DOI: 10.1302/2046-3758.107.BJR-2020-0370.R1
30.
LiuKZhangDWangW, et al.Nanoparticle-based drug delivery system—a target strategy for osteoarthritis treatment. J Nanomater2021; 2021: 1–15. DOI: 10.1155/2021/4064983
31.
JacobsBYAllenKD. Factors affecting the reliability of behavioral assessments for rodent osteoarthritis models. Lab Anim2020; 54: 317–329. DOI: 10.1177/0023677219867715
32.
Lampropoulou-AdamidouK, et al.Useful animal models for the research of osteoarthritis. Eur J Orthop Surg Traumatol2014; 24: 263–271. DOI: 10.1007/s00590-013-1205-2
33.
AshrafSMappPIShahtaheriSM, et al.Effects of carrageenan induced synovitis on joint damage and pain in a rat model of knee osteoarthritis. Osteoarthritis Cartilage2018; 26: 1369–1378. DOI: 10.1016/j.joca.2018.07.001
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
